In the last 12 months, insiders at DELCATH SYSTEMS, INC. ($DCTH) filed 93 transactions with the SEC: 7 open-market purchases totaling $487,374 and 0 sales totaling $0. Net insider sentiment: net buying.
DELCATH SYSTEMS, INC. operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Aharon Gil (Director) — 10 transactions totaling $6,613,410
- SALAMON STEVEN A J (Director) — 10 transactions totaling $6,613,410
- Rosalind Advisors, Inc. (Director) — 10 transactions totaling $6,513,413
- MICHEL GERARD J (CHIEF EXECUTIVE OFFICER) — 10 transactions totaling $448,356
- Vukovic Vojo (CHIEF MEDICAL OFFICER) — 7 transactions totaling $300,761
View all SEC Filings for DELCATH SYSTEMS, INC. (DCTH).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | Pennell Sandra | Chief Financial Officer | P | Common Stock | 5533 | $9.04 | 77,018.0000 | 40,056,814 | 7.74% | 0.01% |
| March 2, 2026 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | P | Common Stock | 11200 | $8.96 | 342,034.0000 | 40,056,814 | 3.39% | 0.03% |
| Feb. 17, 2026 | Hoffman David L. | GEN'L COUNSEL, CCO & SECY | A | Restricted Stock Units | 28250 | $0.00 | 28,250.0000 | 40,056,814 | 9999.99% | 0.07% |
| Feb. 17, 2026 | Hoffman David L. | GEN'L COUNSEL, CCO & SECY | A | Stock Option (Right to Buy) | 56500 | $0.00 | 56,500.0000 | 40,056,814 | 9999.99% | 0.14% |
| Feb. 17, 2026 | Muir Kevin | GM INTERVENTIONAL ONCOLOGY | A | Restricted Stock Units | 28250 | $0.00 | 28,250.0000 | 40,056,814 | 9999.99% | 0.07% |
| Feb. 17, 2026 | Muir Kevin | GM INTERVENTIONAL ONCOLOGY | A | Stock Option (Right to Buy) | 56500 | $0.00 | 56,500.0000 | 40,056,814 | 9999.99% | 0.14% |
| Feb. 17, 2026 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Units | 97500 | $0.00 | 97,500.0000 | 40,056,814 | 9999.99% | 0.24% |
| Feb. 17, 2026 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 40,056,814 | 9999.99% | 0.49% |
| Feb. 17, 2026 | Rook Martha S. | CHIEF OPERATING OFFICER | A | Restricted Stock Units | 28250 | $0.00 | 28,250.0000 | 40,056,814 | 9999.99% | 0.07% |
| Feb. 17, 2026 | Rook Martha S. | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 56500 | $0.00 | 56,500.0000 | 40,056,814 | 9999.99% | 0.14% |
| Feb. 17, 2026 | Vukovic Vojo | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 28250 | $0.00 | 28,250.0000 | 40,056,814 | 9999.99% | 0.07% |
| Feb. 17, 2026 | Vukovic Vojo | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 56500 | $0.00 | 56,500.0000 | 40,056,814 | 9999.99% | 0.14% |
| Feb. 17, 2026 | Pennell Sandra | Chief Financial Officer | A | Restricted Stock Units | 28250 | $0.00 | 28,250.0000 | 40,056,814 | 9999.99% | 0.07% |
| Feb. 17, 2026 | Pennell Sandra | Chief Financial Officer | A | Stock Option (Right to Buy) | 56500 | $0.00 | 56,500.0000 | 40,056,814 | 9999.99% | 0.14% |
| Nov. 21, 2025 | Sylvester John Richard | Not found | P | Common Stock | 4386 | $8.89 | 14,936.0000 | 40,056,814 | 41.57% | 0.01% |
| Nov. 11, 2025 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | P | Common Stock | 11500 | $8.53 | 330,834.0000 | 40,056,814 | 3.60% | 0.03% |
| June 12, 2025 | Vukovic Vojo | CHIEF MEDICAL OFFICER | M | Common Stock | 42000 | $4.78 | 168,882.0000 | 28,511,393 | 33.10% | 0.15% |
| June 12, 2025 | Vukovic Vojo | CHIEF MEDICAL OFFICER | M | Employee Stock Option (Right to Buy) | 42000 | $0.00 | 58,500.0000 | 28,511,393 | 41.79% | 0.15% |
| May 15, 2025 | CZEREPAK ELIZABETH | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 28,511,393 | 9999.99% | 0.08% |
| May 15, 2025 | Aharon Gil | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 28,511,393 | 9999.99% | 0.08% |
| May 15, 2025 | Martell Bridget A | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 28,511,393 | 9999.99% | 0.08% |
| May 15, 2025 | Sylvester John Richard | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 28,511,393 | 9999.99% | 0.08% |
| May 15, 2025 | SALAMON STEVEN A J | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 28,511,393 | 9999.99% | 0.08% |
| May 5, 2025 | Aharon Gil | Director | X | Common shares | 400000 | $10.00 | 3,413,468.0000 | 28,511,393 | 13.27% | 1.40% |
| May 5, 2025 | Rosalind Advisors, Inc. | Director | X | Common shares | 400000 | $10.00 | 3,413,468.0000 | 28,511,393 | 13.27% | 1.40% |
| May 5, 2025 | SALAMON STEVEN A J | Director | X | Common shares | 400000 | $10.00 | 3,413,468.0000 | 28,511,393 | 13.27% | 1.40% |
| Feb. 7, 2025 | Pennell Sandra | Chief Financial Officer | A | Stock Option (Right to Buy) | 113000 | $0.00 | 113,000.0000 | 28,511,393 | 9999.99% | 0.40% |
| Feb. 7, 2025 | Hoffman David L. | GEN'L COUNSEL, CCO & SECY | A | Stock Option (Right to Buy) | 113000 | $0.00 | 113,000.0000 | 28,511,393 | 9999.99% | 0.40% |
| Feb. 7, 2025 | Muir Kevin | GM INTERVENTIONAL ONCOLOGY | A | Stock Option (Right to Buy) | 113000 | $0.00 | 113,000.0000 | 28,511,393 | 9999.99% | 0.40% |
| Feb. 7, 2025 | Rook Martha S. | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 113000 | $0.00 | 113,000.0000 | 28,511,393 | 9999.99% | 0.40% |
| Feb. 7, 2025 | Vukovic Vojo | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 113000 | $0.00 | 113,000.0000 | 28,511,393 | 9999.99% | 0.40% |
| Feb. 7, 2025 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 390000 | $0.00 | 390,000.0000 | 28,511,393 | 9999.99% | 1.37% |
| Dec. 24, 2024 | SALAMON STEVEN A J | Director | C | Common shares | 250000 | $10.00 | 3,013,468.0000 | 32,345,672 | 9.05% | 0.77% |
| Dec. 24, 2024 | SALAMON STEVEN A J | Director | M | Pre-funded Warrants | 603954 | $9.99 | 1,323,919.0000 | 32,345,672 | 83.89% | 1.87% |
| Dec. 24, 2024 | Rosalind Advisors, Inc. | Director | C | Common shares | 250000 | $10.00 | 3,013,468.0000 | 32,345,672 | 9.05% | 0.77% |
| Dec. 24, 2024 | Aharon Gil | Director | M | Pre-funded Warrants | 603954 | $9.99 | 1,323,919.0000 | 32,345,672 | 83.89% | 1.87% |
| Dec. 24, 2024 | Aharon Gil | Director | C | Common shares | 250000 | $10.00 | 3,013,468.0000 | 32,345,672 | 9.05% | 0.77% |
| Dec. 24, 2024 | Rosalind Advisors, Inc. | Director | M | Pre-funded Warrants | 603954 | $9.99 | 1,323,919.0000 | 32,345,672 | 83.89% | 1.87% |
| Oct. 30, 2024 | Aharon Gil | Director | M | Tranche B warrants to purchase F-4 Preferred Stock | 500 | $1000.00 | 0.0000 | 32,345,672 | 0.00% | 0.00% |
| Oct. 30, 2024 | Rosalind Advisors, Inc. | Director | M | Tranche B warrants to purchase F-4 Preferred Stock | 500 | $1000.00 | 0.0000 | 32,345,672 | 0.00% | 0.00% |
| Oct. 30, 2024 | Rosalind Advisors, Inc. | Director | H | 8% CONVERTIBLE NOTE | 0 | $0.00 | 0.0000 | 32,345,672 | 0.00% | 0.00% |
| Oct. 30, 2024 | SALAMON STEVEN A J | Director | H | 8% CONVERTIBLE NOTE | 0 | $0.00 | 0.0000 | 32,345,672 | 0.00% | 0.00% |
| Oct. 30, 2024 | SALAMON STEVEN A J | Director | M | Tranche B warrants to purchase F-4 Preferred Stock | 500 | $1000.00 | 0.0000 | 32,345,672 | 0.00% | 0.00% |
| Oct. 30, 2024 | Aharon Gil | Director | H | 8% CONVERTIBLE NOTE | 0 | $0.00 | 0.0000 | 32,345,672 | 0.00% | 0.00% |
| Oct. 22, 2024 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | M | Common Stock | 16666 | $6.00 | 319,334.0000 | 32,345,672 | 5.51% | 0.05% |
| Oct. 22, 2024 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | M | Tranche B Warrants to Purchase Common Stock | 16666 | $0.13 | 0.0000 | 32,345,672 | 100.00% | 0.05% |
| May 23, 2024 | STOLL ROGER G PHD | Not found | A | Stock Option (Right to Buy) | 19682 | $0.00 | 19,682.0000 | 16,229,931 | 9999.99% | 0.12% |
| May 23, 2024 | STOLL ROGER G PHD | Not found | D | Stock Option (Right to Buy) | 19682 | $0.00 | 0.0000 | 16,229,931 | 100.00% | 0.12% |
| May 23, 2024 | STOLL ROGER G PHD | Not found | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 16,229,931 | 9999.99% | 0.06% |
| May 23, 2024 | STOLL ROGER G PHD | Not found | D | Stock Option (Right to Buy) | 9000 | $0.00 | 0.0000 | 16,229,931 | 100.00% | 0.06% |
| May 23, 2024 | STOLL ROGER G PHD | Not found | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 16,229,931 | 9999.99% | 0.06% |
| May 23, 2024 | STOLL ROGER G PHD | Not found | D | Stock Option (Right to Buy) | 9000 | $0.00 | 0.0000 | 16,229,931 | 100.00% | 0.06% |
| May 23, 2024 | STOLL ROGER G PHD | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 16,229,931 | 9999.99% | 0.25% |
| May 23, 2024 | STOLL ROGER G PHD | Not found | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 16,229,931 | 100.00% | 0.25% |
| May 23, 2024 | STOLL ROGER G PHD | Not found | A | Stock Option (Right to Buy) | 142 | $0.00 | 142.0000 | 16,229,931 | 9999.99% | 0.00% |
| May 23, 2024 | STOLL ROGER G PHD | Not found | D | Stock Option (Right to Buy) | 142 | $0.00 | 0.0000 | 16,229,931 | 100.00% | 0.00% |
| May 23, 2024 | Sylvester John Richard | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 16,229,931 | 9999.99% | 0.14% |
| May 23, 2024 | Aharon Gil | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 16,229,931 | 9999.99% | 0.14% |
| May 23, 2024 | Martell Bridget A | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 16,229,931 | 9999.99% | 0.14% |
| May 23, 2024 | CZEREPAK ELIZABETH | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 16,229,931 | 9999.99% | 0.14% |
| May 23, 2024 | SALAMON STEVEN A J | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 16,229,931 | 9999.99% | 0.14% |
| April 18, 2024 | Rosalind Advisors, Inc. | Director | C | Common Shares | 991615 | $0.00 | 2,763,468.0000 | 16,229,931 | 55.96% | 6.11% |
| April 18, 2024 | SALAMON STEVEN A J | Director | C | Common Shares | 991615 | $0.00 | 2,732,586.0000 | 16,229,931 | 56.96% | 6.11% |
| April 18, 2024 | Rosalind Advisors, Inc. | Director | X | Common Shares | 619946 | $0.01 | 2,763,468.0000 | 16,229,931 | 28.92% | 3.82% |
| April 18, 2024 | Aharon Gil | Director | X | Common Shares | 619946 | $0.01 | 2,681,271.0000 | 16,229,931 | 30.08% | 3.82% |
| April 18, 2024 | Aharon Gil | Director | C | Common Shares | 991615 | $0.00 | 2,681,271.0000 | 16,229,931 | 58.69% | 6.11% |
| April 18, 2024 | SALAMON STEVEN A J | Director | X | Common Shares | 619946 | $0.01 | 2,732,586.0000 | 16,229,931 | 29.34% | 3.82% |
| April 18, 2024 | Rosalind Advisors, Inc. | Director | C | Common Shares | 991615 | $0.00 | 2,763,468.0000 | 16,229,931 | 55.96% | 6.11% |
| April 18, 2024 | Aharon Gil | Director | X | Common Shares | 619946 | $6199.46 | 2,681,271.0000 | 16,229,931 | 30.08% | 3.82% |
| April 18, 2024 | Aharon Gil | Director | C | Common Shares | 991615 | $0.00 | 2,681,271.0000 | 16,229,931 | 58.69% | 6.11% |
| April 18, 2024 | SALAMON STEVEN A J | Director | C | Common Shares | 991615 | $0.00 | 2,732,586.0000 | 16,229,931 | 56.96% | 6.11% |
| April 18, 2024 | SALAMON STEVEN A J | Director | X | Common Shares | 619946 | $6199.46 | 2,732,586.0000 | 16,229,931 | 29.34% | 3.82% |
| April 18, 2024 | Rosalind Advisors, Inc. | Director | X | Common Shares | 619946 | $6199.46 | 2,763,468.0000 | 16,229,931 | 28.92% | 3.82% |
| March 19, 2024 | Aharon Gil | Director | P | Common Shares | 26882 | $3.72 | 1,069,710.0000 | 16,229,931 | 2.58% | 0.17% |
| March 18, 2024 | Rook Martha S. | CHIEF OPERATING OFFICER | A | Employee Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 16,229,931 | 9999.99% | 0.77% |
| March 19, 2024 | Rosalind Advisors, Inc. | Director | P | Pre-funded Warrants | 619946 | $3.71 | 836,133.0000 | 16,229,931 | 286.76% | 3.82% |
| March 19, 2024 | SALAMON STEVEN A J | Director | P | Common Shares | 26882 | $3.72 | 1,121,025.0000 | 16,229,931 | 2.46% | 0.17% |
| March 19, 2024 | Pennell Sandra | SVP OF FINANCE, PFO AND PAO | A | Common Stock | 26881 | $3.72 | 61,052.0000 | 16,229,931 | 78.67% | 0.17% |
| March 19, 2024 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | A | Common Stock | 40323 | $3.72 | 302,668.0000 | 16,229,931 | 15.37% | 0.25% |
| March 19, 2024 | Vukovic Vojo | CHIEF MEDICAL OFFICER | A | Common Stock | 26882 | $3.72 | 126,882.0000 | 16,229,931 | 26.88% | 0.17% |
| March 19, 2024 | Hoffman David L. | GEN'L COUNSEL, CCO & SECY | A | Common Stock | 20161 | $3.72 | 74,330.0000 | 16,229,931 | 37.22% | 0.12% |
| March 19, 2024 | Muir Kevin | GM INTERVENTIONAL ONCOLOGY | A | Common Stock | 13441 | $3.72 | 18,582.0000 | 16,229,931 | 261.45% | 0.08% |
| Feb. 8, 2023 | Dias Anthony | VP FINANCE | A | Stock Option (Right to Buy) | 31200 | $0.00 | 31,200.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 301500 | $0.00 | 301,500.0000 | 16,229,931 | 9999.99% | 1.86% |
| Feb. 12, 2024 | Hoffman David L. | GEN'L COUNSEL, CCO & SECY | A | Stock Option (Right to Buy) | 100500 | $0.00 | 100,500.0000 | 16,229,931 | 9999.99% | 0.62% |
| Feb. 12, 2024 | Pennell Sandra | SVP OF FINANCE, PFO AND PAO | A | Stock Option (Right to Buy) | 100500 | $0.00 | 100,500.0000 | 16,229,931 | 9999.99% | 0.62% |
| Feb. 12, 2024 | Muir Kevin | VP COMMERCIAL OPERATIONS | A | Stock Option (Right to Buy) | 100500 | $0.00 | 100,500.0000 | 16,229,931 | 9999.99% | 0.62% |
| Feb. 12, 2024 | Vukovic Vojo | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 100500 | $0.00 | 100,500.0000 | 16,229,931 | 9999.99% | 0.62% |
| Feb. 8, 2023 | Muir Kevin | VP COMMERCIAL OPERATIONS | A | Stock Option (Right to Buy) | 46800 | $0.00 | 46,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Purpura John | CHIEF OPERATING OFFICER | A | Stock Option (Right to Buy) | 56160 | $0.00 | 56,160.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | John Johnny | SVP CLINICAL DEV & MED AFFAIRS | A | Stock Option (Right to Buy) | 46800 | $0.00 | 46,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 140400 | $0.00 | 140,400.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2023 | Hoffman David L. | GEN'L COUNSEL, CCO & SECY | A | Stock Option (Right to Buy) | 46800 | $0.00 | 46,800.0000 | 0 | 9999.99% | 0.00% |